BREAKING: Largest Human Cancer Study of Ivermectin + Mebendazole Is Now PEER-REVIEWED and PUBLISHED in a MAJOR Cancer Journal
84.4% of cancer patients taking ivermectin + mebendazole for 6 months declared either CANCER DISAPPEARANCE, TUMOR REGRESSION, or CANCER STABILIZATION.
Our study, “Real-world Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort,” is now peer-reviewed and published in Anticancer Research—a major international oncology journal of the International Institute of Anticancer Research (IIAR), established in 1995.
The results represent one of the most compelling clinical signals ever documented for repurposed anti-parasitic therapies in oncology.
A diverse population of cancer patients (n=197) was prescribed compounded ivermectin–mebendazole through a U.S. telemedicine platform, with each capsule containing 25 mg ivermectin and 250 mg mebendazole.
Participants were followed for approximately six months using standardized digital surveys assessing cancer outcomes, medication adherence, and tolerability.
At approximately six months post-treatment initiation, we observed an 84.4% Clinical Benefit Ratio (CBR)—meaning more than four out of five patients reported either:
No evidence of disease (32.8%)
Tumor regression (15.6%)
or Cancer stabilization (36.1%)
Importantly, adherence was remarkably high, with 86.9% completing the initial prescription and 66.4% remaining on therapy at six months.
Side effects were predominantly mild and manageable, reported in 25.4% of patients (primarily gastrointestinal), with 93.6% of those experiencing side effects continuing treatment after minor dosing adjustments.
This groundbreaking peer-reviewed publication was made possible through a unique collaboration between The Wellness Company, the McCullough Foundation, and the Chairman of the President’s Cancer Panel—uniting real-world clinical data, frontline medical experience, and epidemiologic expertise to evaluate inexpensive, repurposed therapies with major translational potential.
With these extraordinarily promising results, double-blind, placebo-controlled clinical trials are now required.
In the meantime, many cancer patients are exercising their right to try.
@twc_health@McCulloughFund@IIAR_Journals@P_McCulloughMD@DrHarveyRisch@DrKellyVictory@jathorpmfm@drdrew@PeterGillooly@FosterCoulson
@Partisangirl ABC FourCorners Exposes How AFP Directed Anti-Semitic Attacks In Australia By Nomads Motorcycle Club In Exchange For Dropping Drug Importation Charges
https://t.co/j5b87dEhOu
VIDEO: GMO Ticks and Mosquitos Have Been Caught on Video Raining Down From the Sky Across the United States. Gov't Whistleblowers, Top Scientists and Others Are Now Documenting the Fact That This is Part of a Larger, Bill Gates-Backed Human Engineering Program. Bottom Line — This Constitutes a Violation of Medical Informed Consent Under the Nuremberg Code and is Punishable By Death.
One tick bite made this man allergic to red meat.
Now over 450,000 Americans are allergic to beef & dairy and the number is rising.
What’s is going on?
KEY INTEL: Bill Gates Has Been Caught Funding Research Directly Linked To GMO-Modified Lone Star Ticks That Cause A Meat Allergy That Kills Anyone Who Eats Beef After Being Bitten!
Alex Jones Delivers Powerful Deep Dive Breakdown Of How The Globalist Mad Scientists Want To Rape Your Body With Their Flying / Crawling Syringes!
🔴WATCH/SHARE ALEX JONES LIVE HERE:
https://t.co/LvKcY5ZGV8
🚨 Les Wexner just CONFIRMED that Epstein worked for the ROTHSCHILD FAMILY—the architects of the Federal Reserve—as well as Jeff Bezos & Google.
His lawyer then leaned in and said: "I will f*cking kiII you if you answer another question with more than 5 words."
Umm WHAT?!? 😳😬
American citizen and journalist Tucker Carlson detained in Israel after interviewing our U.S. Ambassador Mike Huckabee.
We won’t tolerate this.
You just made it worse.